Cancerous toxin is the key pathogenic factor of malignant tumor

Journal of Chinese Integrative Medicine

Volumn 6, Issue 2, 2008, Pages 111-114

  Ling, Chang Quan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Carcinoma; Chinese traditional; Etiological factors and pathogenesis (traditional Chinese medicine); Medicine; Neoplasms; Toxin

Indexed keywords

CARCINOGEN;

BODY EQUILIBRIUM; CANCER RISK; CANCER THERAPY; CARCINOGENESIS; CHINESE MEDICINE; EDITORIAL; HUMAN; MALIGNANT NEOPLASTIC DISEASE; RISK FACTOR;

DIAGNOSIS, DIFFERENTIAL; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; NEOPLASMS;

EID: 39149099996     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20080201     Document Type: Editorial

References (21)

1. Wang JH. The status and effect of traditional Chinese medicine in treatment of malignant tumor. Jiangsu Zhong Yi. 2001; 22(11): 1-3.
2. Ling CQ. Problems in cancer treatment and major research of integrative medicine. Zhong Xi Yi Jie He Xue Bao. 2003; 1(3): 168-170. English.
3. Yu RC. Oncology of traditional Chinese medicine. Beijing: Science Press. 1983: 12-25.
4. Xia X, Wang QQ. Collection of academic experience of Shanghai famous traditional Chinese medicine doctors. Beijing: People's Medical Publishing House. 2006: 896-909.
5. Yu LF. Collected works of Shanghai famous and senior traditional Chinese medicine doctors' experience in treating digestive system diseases. Beijing: China Press of Traditional Chinese Medicine. 2007: 51-72.
6. Huang YS. Tentative analysis of treatment of lung cancer with the theory of cancerous toxin. Shannxi Zhong Yi. 2005; 26(10): 1077-1078.
7. Shu P, Liu SL. Tentative analysis of differentiation and treatment structure of traditional Chinese medicine oncology. Jilin Zhong Yi Yao. 2005; 25(7): 47.
8. Li JY. Exploration of concept of pathology and clinical treatment of cancerous toxin. Jiangxi Zhong Yi Yao. 2005; 36(8): 14-15.
9. Chen SQ. Professor Zhou Zhong-ying's experience on the treatment of tumor by differentiation of cancerous toxin. Xin Zhong Yi. 2004; 36(2): 7-9.
10. Dai XJ, Zhu YM. Tentative analysis of tumour pathology and pharmacology of "treatment on the basis of toxin" in treating tumour and clinical practice on indication. Zhong Yi Yao Xue Kan. 2002; 20(1): 67.
11. Jia LQ, Huang JC. Treating the malignant tumor by "combatting toxin with toxin" prescription. Zhong Ri You Hao Yi Yuan Xue Bao. 2000; 14(2): 117-120.
12. Lu Y. Discussion and study of cancer treatment. Hubei Zhong Yi Za Zhi. 1992; 14(4): 42.
13. Chang FY, Wang YY. Toxic pathogen theory of apoplexy. Beijing Zhong Yi Yao Da Xue Xue Bao. 2004; 27 (1): 3-6.
14. Liu GS. Study of toxin and pathology. Shandong Zhong Yi Xue Yuan Xue Bao. 1989; 13(1): 3-5.
15. Liu BS. Oncology in human digestive system. Beijing: People's Medical Publishing House. 2004: 4.
16. Cai SR, Zheng S, Zhang SZ. Multivariate analysis of prognostic factors in colorectal cancer patients with different age. Zhonghua Zhong Liu Za Zhi. 2005; 27 (8): 483-485.
17. Wang ZY, Tang XH, Liu SX, et al. Contrast treatment of clinical and endoscopy to patients with colorectal cancer at different age group. Zhongguo Ji Ceng Yi Yao. 2006; 13(7): 1173-1174.
18. Chen J, Xu DS, Zhang Y, et al. The relationship between age and the clinical characteristics of malignant kidney neoplasms in adult patients. Zhonghua Mi Niao Wai Ke Za Zhi. 2006; 27(2): 93-96.
19. Cho SJ, Yoon JH, Hwang SS, et al. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? J Gastroenterol Hepatol. 2007; 22(8): 1226-1231.
20. Tang ZY. Clinical hepatocellular carcinoma. Shanghai: Shanghai Scientific and Technical Education Publishing House. 2001:16.
21. Gary Stix. A malignant flame. Understanding chronic inflammation, which contributes to heart disease, Alzheimer's and a variety of other ailments, may be a key to unlocking the mysteries of cancer. Sci Am. 2007; 297(1): 60-67.